000			01605 a2200481 4500
005			20250512204746.0
264		0	_c19820621
008			198206s 0 0 eng d
022			_a0166-3542
024	7		_a10.1016/0166-3542(81)90011-5 _2doi
040			_aNLM _beng _cNLM
100	1		_aBrigden, D
245	0	0	_aAcyclovir - a review of the preclinical and early clinical data of a new antiherpes drug. _h[electronic resource]
260			_bAntiviral research _cNov 1981
300			_a203-12 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Review
650	0	4	_aAcyclovir
650	0	4	_aAnimals
650	0	4	_aClinical Trials as Topic
650	0	4	_aDrug Resistance, Microbial
650	0	4	_aGuanine _xanalogs & derivatives
650	0	4	_aGuinea Pigs
650	0	4	_aHerpes Simplex _xdrug therapy
650	0	4	_aHerpesviridae _xdrug effects
650	0	4	_aHerpesviridae Infections _xdrug therapy
650	0	4	_aHerpesvirus 3, Human _xdrug effects
650	0	4	_aHerpesvirus 4, Human _xdrug effects
650	0	4	_aHumans
650	0	4	_aIntestinal Absorption
650	0	4	_aKeratitis, Dendritic _xdrug therapy
650	0	4	_aKidney _xdrug effects
650	0	4	_aKinetics
650	0	4	_aMice
650	0	4	_aPhosphorylation
650	0	4	_aRabbits
650	0	4	_aSimplexvirus _xdrug effects
650	0	4	_aTime Factors
700	1		_aFiddian, P
700	1		_aRosling, A E
700	1		_aRavenscroft, T
773	0		_tAntiviral research _gvol. 1 _gno. 4 _gp. 203-12
856	4	0	_uhttps://doi.org/10.1016/0166-3542(81)90011-5 _zAvailable from publisher's website
999			_c6280535 _d6280535